Principles and Current Topics Concerning Management of Tyrosine Kinase Inhibitor Therapy for Chronic Myelogenous Leukemia

Junya Kuroda^* and Masafumi Taniwaki

Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan

^*Corresponding Author: Junya Kuroda, MD, PhD, Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan, Tel: +81 75 251 5740, Fax: +81 75 251 5743 Email: